| NDC Code | 33342-003-09 |
|---|
| Package Description | 60 TABLET in 1 BOTTLE (33342-003-09) |
|---|
| Product NDC | 33342-003 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Lamivudine And Zidovudine |
|---|
| Non-Proprietary Name | Lamivudine And Zidovudine |
|---|
| Dosage Form | TABLET |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180830 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090679 |
|---|
| Manufacturer | Macleods Pharmaceuticals Limited |
|---|
| Substance Name | LAMIVUDINE; ZIDOVUDINE |
|---|
| Strength | 150; 300 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|